rs397516837
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003242.6(TGFBR2):c.118G>A(p.Asp40Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003242.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR2 | ENST00000295754.10 | c.118G>A | p.Asp40Asn | missense_variant | Exon 2 of 7 | 1 | NM_003242.6 | ENSP00000295754.5 | ||
TGFBR2 | ENST00000359013.4 | c.193G>A | p.Asp65Asn | missense_variant | Exon 3 of 8 | 1 | ENSP00000351905.4 | |||
TGFBR2 | ENST00000672866.1 | n.1714G>A | non_coding_transcript_exon_variant | Exon 2 of 7 | ||||||
TGFBR2 | ENST00000673250.1 | n.242G>A | non_coding_transcript_exon_variant | Exon 3 of 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Asp40Asn varian t in TGFBR2 has not been reported in the literature or identified in our laborat ory in over 380 individuals. This residue is not highly conserved and computatio nal analyses (PolyPhen2, SIFT, AlignGVGD) do not suggest a high likelihood of im pact to the normal function of the protein. It should be noted that the sensitiv ity and specificity of these computational programs has not been determined by o ur laboratory. Therefore, the clinical significance of this variant cannot be de termined at this time. The clinical significance of this variant should be inter preted in the context of this individual's clinical manifestations. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at